Too much like us? Researchers uncover key reason a promising cancer therapy is often unsuccessful

Too much like us? Researchers uncover key reason a promising cancer therapy is often unsuccessful

Neoantigens, which are molecules found on tumor cells that incorporate mutations, help our immune system fight cancers and could be the most promising components of future cancer vaccines—if only scientists knew with a high degree of certainty which neoantigens work.

A collaboration of scientists…

Read More about Too much like us? Researchers uncover key reason a promising cancer therapy is often unsuccessful

New markup language a FAIR way of sharing data in enzymology and catalysis

New markup language a FAIR way of sharing data in enzymology and catalysis

An international collaboration of scientists, including Santiago Schnell, William K. Warren Foundation Dean of the College of Science, developed a new markup language to improve the way experiments can be reproduced in the biomedical sciences, especially within fields that study how enzymes speed up chemical reactions.

Read More about New markup language a FAIR way of sharing data in enzymology and catalysis

Clark awarded NIH Pioneer Award, the first in Indiana

Clark awarded NIH Pioneer Award, the first in Indiana

Patricia L. Clark, the John Cardinal O’Hara, C.S.C. Professor of Chemistry and Biochemistry and associate vice president for research at the University of Notre Dame, has received a prestigious Director’s Pioneer Award from the National Institutes of Health. These awards are given to exceptionally creative scientists advancing high-risk, high-impact research. Clark is the first researcher in Indiana to receive this distinguished award since the program’s inception in 2004.

Read More about Clark awarded NIH Pioneer Award, the first in Indiana